Distinguished Scientists Seminar set for Nov. 2

Kevin Pruitt, Ph.D.

The next Distinguished Scientists Seminar will feature Kevin Pruitt, Ph.D., an associate professor of pharmacology at the University of North Carolina at Chapel Hill’s Lineberger Comprehensive Cancer Center. 

Pruitt’s seminar, “Exploring novel regulation of Wnt signaling in epigenetics and immunomodulation of the tumor microenvironment,” is set for Thursday, Nov. 2, at 4 p.m. in the first-floor auditorium of the Medical Sciences Building. Students and faculty are invited to attend the lecture, hosted by Santanu Dasgupta, Ph.D., the Department of Pathology and the Mitchell Cancer Institute. 

Pruitt completed Ph.D. studies in pharmacology at the University of North Carolina at Chapel Hill. He continued postdoctoral training in cancer epigenetics at the Johns Hopkins University School of Medicine. His lab research focuses on epigenetics, aromatase regulation and how Wnt signaling influences immune cell trafficking to the tumor microenvironment. 

The Distinguished Scientists Seminar (DSS) program comprises invited talks by leading scientists from outside institutions. Speakers are selected to complement the Graduate Training Program in the Whiddon College of Medicine and cover a wide range of cutting-edge biomedical research.  

Learn more about the DSS program and view the full schedule of seminars.